Literature DB >> 2176499

Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules.

J A Raleigh1, C J Koch.   

Abstract

Reductive activation of 2-nitroimidazoles in the presence of bovine serum albumin (BSA) led to binding of the nitroheterocycles to the protein. The binding was most efficient to BSA in which protein disulfides had been reduced to thiol groups. Protein thiols were at least twenty times more efficient than other protein, RNA or DNA nucleophiles in binding the reductively-activated nitroheterocycles. This result is of practical importance in the development of immunoassays for 2-nitroimidazoles as hypoxia markers in normal and tumor tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176499     DOI: 10.1016/0006-2952(90)90086-z

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

1.  Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.

Authors:  Nilesh K Wagh; Zhengyuan Zhou; Sunny M Ogbomo; Wen Shi; Susan K Brusnahan; Jered C Garrison
Journal:  Bioconjug Chem       Date:  2012-02-16       Impact factor: 4.774

Review 2.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

3.  Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole.

Authors:  S C Chou; P M Flood; J A Raleigh
Journal:  Br J Cancer Suppl       Date:  1996-07

4.  Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse.

Authors:  William S Wright; Amit Singh Yadav; Robert M McElhatten; Norman R Harris
Journal:  Exp Eye Res       Date:  2012-03-13       Impact factor: 3.467

5.  Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.

Authors:  Belinda S Hall; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

6.  Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer." in this issue of EJNMMI.

Authors:  Cameron J Koch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02       Impact factor: 9.236

7.  Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.

Authors:  Cameron J Koch; Joshua S Scheuermann; Chaitanya Divgi; Kevin D Judy; Alexander V Kachur; Richard Freifelder; Janet S Reddin; Joel Karp; James B Stubbs; Stephen M Hahn; Jason Driesbaugh; Deborah Smith; Susan Prendergast; Sydney M Evans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-29       Impact factor: 9.236

Review 8.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

9.  Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats.

Authors:  William S Wright; Robert M McElhatten; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2009-12-11       Impact factor: 3.467

10.  Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.

Authors:  P Mahy; M De Bast; P H Leveque; J Gillart; D Labar; J Marchand; V Gregoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.